Journal of Pathology, Microbiology and Immunology - the APMIS journal
Edited By: T. Bjarnsholt, Peter Østrup Jensen and Alexandra G. Gheorghe
APMIS is a monthly journal that encompasses a diverse range of topics in microbiology, immunology, and pathology. It explores a spectrum of medical research, infection, inflammation, immunity, and related subjects in both humans and animals The journal provides valuable insights into global health issues and advancements in diagnostics and treatment. With its multidisciplinary approach, APMIS aims to promote collaboration and knowledge exchange among researchers and practitioners in the field.
Journal Metrics
- 4.7CiteScore
- 2.6Journal Impact Factor
- 21%Acceptance rate
- 18 days Submission to first decision
Focus Issues
2023 Focus Issue: Fungal infections: diagnostics and therapeutics
We are proud to present a new focus issue to illustrate the importance of Fungal Infections in Human and Animal Disease. This issue is edited by guest editors Gordon Ramage and Aase Bengaard Andersen and includes articles and reviews that focus on contemporary issues related to diagnostics and therapeutics associated with pathogenic fungi.
2022 Focus Issue: Status on human microbiome in disease and pathology
We are pleased to present a focus issue on Status on human microbiome in disease and pathology. In this focus issue we collected reviews and manuscripts describing direct evidence for the current status of what is known about how the human microbiome, including bacteria, vira and fungi, is involved in disease and pathology.
2021 Focus Issue on Pandemics: Past, now, and in the future
We are delighted to present a focus issue on Pandemics: Past, now, and in the future. The focus issue features essential reading from invited researchers from various disciplines to give a state‐of‐the‐art review of their research field within different infectious organisms and the association to cancer. Thank you to the Guest Editors Thomas Bjarnsholt and Henrik Calum, and the authors who contributed to the special issue.
Two new features for APMIS submissions
We now have two new functions available which help both authors and our editors; a new AI-engine which automatically checks your manuscript on 50 parameters re technical aspects and potential omissions in a manuscript (structure, word count, author affiliation, references, ethical forms, and many more).
For our editors a new built-in search engine provides suggestions for potential reviewers by ranking them based on their experience, publications, activity, etc. This will enable us to get the most relevant reviewers for your manuscript and hopefully speed up the review process as well.
We look forward to receiving your submissions and that you find the new features useful!.
Articles
Unraveling the Transcriptomic Adaptations of Streptococcus mutans Biofilm to the Post-Biotic Impact of Lactiplantibacillus plantarum
-  21 July 2025
MiR-145-5p Regulates Inflammatory Response via Targeting CD40 in Chronic Rhinosinusitis With Nasal Polyposis
-  18 July 2025
Emerging Nanomaterial Strategies for Antibacterial and Antibiofilm Applications: Innovations in Bacterial Detection, Mechanistic Understanding, and Therapeutic Interventions to Address Antibiotic Resistance
-  16 July 2025
Downregulation of lncRNA H19 Enhances Radiosensitivity in Colorectal Cancer by Inactivation of the ATR/CHK1 Signaling
-  16 July 2025
In Vitro Activity of Antifungals in Combination With Meropenem or Daptomycin Against Dual Candida albicans–Bacterial Biofilms
-  15 July 2025
Increased susceptibility to azithromycin of Pseudomonas aeruginosa biofilms using RPMI 1640 testing media
- APMIS
-  1086-1095
-  15 April 2024
Real‐world data confirm elexacftor/tezacaftor/ivacaftor modulators halves sweat chloride concentration in eligible people with cystic fibrosis
- APMIS
-  728-733
-  2 August 2024
The criteria for chronic rhinosinusitis in children with cystic fibrosis are rarely fulfilled after initiation of CFTR modulator treatment
- APMIS
-  625-631
-  21 May 2024
Good's syndrome: brief overview of an enigmatic immune deficiency
- APMIS
-  698-704
-  20 September 2023
Rifampicin does not reduce moxifloxacin concentrations at the site of infection and may not improve treatment outcome of a one‐stage exchange surgery protocol of implant‐associated osteomyelitis lesions in a porcine model
- APMIS
-  198-209
-  28 December 2023
Recent issues
- Volume 133, Issue 7July 2025
- Volume 133, Issue 6June 2025
- Volume 133, Issue 5May 2025
- Volume 133, Issue 4April 2025